Management of Refractory Eosinophilic Fasciitis Using Biologic Therapies, Janus Kinase Inhibitors, and Intravenous Immunoglobulin: A Systematic Review.
Mitwalli M, Waked JAA, Sood S, Abduelmula A, Akuffo-Addo E, Yeung J, Mufti A
Journal of Cutaneous Medicine and SurgeryIn the feed 27 Jul 2026, published online 27 Jul 2026, issue 2026 Jul 27, added to PubMed 27 Jul 2026
Topics: Autoimmune & connective tissueBiologicsJAK inhibitors & other targeted pillsConventional systemic
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42504410 · DOI 10.1177/12034754261470759